Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Pharmacotherapy for prevention of post‐traumatic stress disorder

Esta versión no es la más reciente

ver la versión actual 08 julio 2014

Información

DOI:
https://doi.org/10.1002/14651858.CD006239Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 18 octubre 2006see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos mentales comunes

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Jonathan C Ipser

    Correspondencia a: MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, Tygerberg, South Africa

    [email protected]

  • Soraya Seedat

    MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, Tygerberg, South Africa

  • Dan J Stein

    Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa

Contributions of authors

Jonathan Ipser compiled the background and method sections of the protocol. Soraya Seedat reviewed and suggested changes to the protocol. Dan Stein assisted in this process, and also served as a coordinator for the protocol.

Sources of support

Internal sources

  • University of Cape Town, Cape Town, South Africa.

  • MRC Research Unit on Anxiety and Stress Disorders, Cape Town, South Africa.

External sources

  • MRC Research Unit on Anxiety and Stress Disorders, Cape Town, South Africa.

Declarations of interest

The MRC Anxiety and Stress Disorders Research Unit has received funding from almost all pharmaceutical companies involved with psychiatry in South Africa.

Potential conflicts of interest for individual reviewers
Jonathan Ipser has no known conflicts of interest outside of his employment by the MRC Unit on Anxiety and Stress Disorders.

Soraya Seedat has received support from several companies (including GlaxoSmithKline, Eli‐Lilly, Pfizer, Cephalon) and has participated in several clinical trials.

Dan Stein has received research grants and/or consultancy honoraria from Astrazeneca, Eli‐Lilly, GlaxoSmithKline, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, and Wyeth. He has participated in a number of ongoing trials, and has presented data from some of these trials on behalf of the sponsoring companies.

Acknowledgements

The authors are supported by the MRC Research Unit on Anxiety and Stress Disorders (Cape Town, South Africa).

Version history

Published

Title

Stage

Authors

Version

2014 Jul 08

Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD)

Review

Taryn Amos, Dan J Stein, Jonathan C Ipser

https://doi.org/10.1002/14651858.CD006239.pub2

2006 Oct 18

Pharmacotherapy for prevention of post‐traumatic stress disorder

Protocol

Jonathan C Ipser, Soraya Seedat, Dan J Stein

https://doi.org/10.1002/14651858.CD006239

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Adult; Aged; Humans; Middle Aged; Young Adult;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.